Upgrade to SI Premium - Free Trial

Aquestive Therapeutics Inc. (AQST)

3.91 -0.02 (0.51%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/4/26)

Latest Headlines

Form 4 Aquestive Therapeutics, For: May 18 Filed by: Zalewski Thomas A. May 19, 2026 12:02 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 15 Filed by: Barber Daniel May 18, 2026 2:03 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 15 Filed by: Cioffi Melina May 18, 2026 12:37 PM - SEC Filing Form 144 Aquestive Therapeutics, Filed by: Barber Daniel May 15, 2026 4:38 PM - SEC Filing Aquestive Therapeutics (AQST) Reiterated at Market Outperform by Citizens May 15, 2026 4:50 AM - StreetInsider Aquestive Therapeutics Inc. (AQST) Tops Q1 EPS by 6c May 13, 2026 4:13 PM - StreetInsider Form 10-Q Aquestive Therapeutics, For: Mar 31 May 13, 2026 4:09 PM - SEC Filing Form 8-K Aquestive Therapeutics, For: May 12 May 13, 2026 4:05 PM - SEC Filing Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update May 13, 2026 4:01 PM - StreetInsider Aquestive Therapeutics secures $150 million debt facility with Oaktree May 12, 2026 9:31 AM - StreetInsider Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree May 12, 2026 9:31 AM - Globe NewsWire Form 4 Aquestive Therapeutics, For: May 07 Filed by: BRAENDER LORI J May 11, 2026 4:36 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: Boyd Peter E. May 7, 2026 5:34 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: Barber Daniel May 7, 2026 5:34 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: TOTH A ERNEST JR May 7, 2026 5:34 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: Jung Cassie May 7, 2026 5:32 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: BRAENDER LORI J May 7, 2026 5:32 PM - SEC Filing Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET May 6, 2026 7:00 AM - Globe NewsWire Form ARS Aquestive Therapeutics, For: Dec 31 April 24, 2026 5:11 PM - SEC Filing Form DEFA14A Aquestive Therapeutics, April 24, 2026 5:06 PM - SEC Filing Form DEF 14A Aquestive Therapeutics, For: Jun 10 April 24, 2026 5:01 PM - SEC Filing Oppenheimer Assumes Aquestive Therapeutics (AQST) at Outperform April 24, 2026 6:14 AM - StreetInsider Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Barber Daniel April 13, 2026 3:55 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Boyd Peter E. April 13, 2026 3:54 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Jung Cassie April 13, 2026 3:53 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: TOTH A ERNEST JR April 13, 2026 3:53 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Korczynski Sherry April 13, 2026 3:52 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: BRAENDER LORI J April 13, 2026 3:52 PM - SEC Filing Form 3 Aquestive Therapeutics, For: Apr 02 Filed by: Zalewski Thomas A. April 10, 2026 9:56 AM - SEC Filing Form 8-K Aquestive Therapeutics, For: Mar 30 March 30, 2026 7:45 AM - SEC Filing Aquestive completes FDA meeting on Anaphylm drug application March 30, 2026 7:00 AM - StreetInsider Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film March 30, 2026 7:00 AM - StreetInsider Form 8-K Aquestive Therapeutics, For: Mar 16 March 20, 2026 7:36 AM - SEC Filing Aquestive names Thomas Zalewski as chief legal officer March 20, 2026 7:00 AM - StreetInsider Aquestive names Thomas Zalewski as chief legal officer March 20, 2026 7:00 AM - StreetInsider Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer March 20, 2026 7:00 AM - StreetInsider Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors March 19, 2026 9:01 AM - Globe NewsWire AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm March 17, 2026 9:01 AM - PR NewsWire AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Aquestive Therapeutics, Inc. Securities Class Action Lawsuit — The Gross Law Firm March 13, 2026 9:00 AM - Globe NewsWire Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors March 11, 2026 7:01 PM - Globe NewsWire Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Boyd Peter E. March 11, 2026 12:53 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Barber Daniel March 11, 2026 12:53 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: BRAENDER LORI J March 11, 2026 12:52 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Cioffi Melina March 11, 2026 12:52 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: TOTH A ERNEST JR March 11, 2026 12:52 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Korczynski Sherry March 11, 2026 12:51 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Jung Cassie March 11, 2026 12:51 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Davis Matthew W. March 11, 2026 12:50 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Greenhawt Matthew J. March 11, 2026 9:26 AM - SEC Filing Form 3 Aquestive Therapeutics, For: Mar 02 Filed by: Greenhawt Matthew J. March 11, 2026 9:20 AM - SEC Filing Class Action Filed Against Aquestive Therapeutics, Inc. (AQST) Seeking Recovery for Investors - Contact The Gross Law Firm March 10, 2026 9:02 AM - PR NewsWire Full Article List